Compare Hinge Health Inc. Class A Common Stock (HNGE) vs Wells Fargo & Co (WFC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hinge Health Inc. Class A Common Stock vs Wells Fargo & Co — how do they compare? Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.47B), while Wells Fargo & Co trades at $81.5 (market cap $242.83B). The key difference: Wells Fargo & Co is far larger — about 28.7× Hinge Health Inc. Class A Common Stock's market cap, and Wells Fargo & Co pays a 2.47% dividend while Hinge Health Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and Wells Fargo & Co for 88 Days on average.
| HNGE | WFC | |
|---|---|---|
Market Cap | $8.47B | $242.83B |
Volume | 1,624,526 | 21,447,763 |
Sector | Health | Financials |
52-Week High | $105.14 | $96.40 |
52-Week Low | $31.17 | $73.42 |
Typical Hold Time | 0 Days | 88 Days |
Enterprise Value | $8.09B | $425.14B |
Dividend Yield | — | 2.47% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Wells Fargo (WFC) trades at $80.74, down 3.07% today, with a bullish technical signal but mixed indicators. The stock shows strong profitability with a 25.97% net income margin and trades at a P/E of 11.74, below the industry average. Recent earnings beat expectations in two of the last three quarters, and a credit rating upgrade to 'A-' by S&P on October 1, 2026, reflects improved risk management.
The outlook is positive with a consensus price target of $98, implying 21% upside, supported by stable Fed stress tests and potential net interest income growth from rate hikes. Risks include volatile cash flows, with operating cash flow negative in 2025, and sensitivity to economic cycles. Institutional sentiment is balanced with 47% buy and hold ratings each.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →About Wells Fargo & Co
Wells Fargo is one of the largest banks in the United States, with approximately $1.9 trillion in balance sheet assets. The company is split into four primary segments: consumer banking, commercial banking, corporate and investment banking, and wealth and investment management. It is almost entirely focused on the U.S.
Read more on WFC →
